Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL
AUTHORS
Shuhua Cheng / Giorgio Inghirami / Shuo Cheng / Wayne Tam
- PRODUCTS
- CLINICAL LAB SERVICES
- DISEASES
Lymphoma
Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).
Myeloma
Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.
- EXPLORE MENU ⟶
Browse our comprehensive menu of product & testing services.
- PARTNERSHIPS
- SCIENCE
- PUBLICATIONS
- NEWSROOM
- CAREERS
- COMPANY
Home/2018 Publications, Featured Publications, Publications/Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL
- PRODUCTS
- CLINICAL LAB SERVICES
- DISEASES
- PARTNERSHIPS
- SCIENCE
- PUBLICATIONS
- NEWSROOM
- CAREERS
- COMPANY